Decreased chronic GvHD with post-transplant cyclophosphamide versus ATG in patients with myelofibrosis allografted with an unrelated donor: a study from the Chronic Malignancies Working Party of the EBMT

• Chalandon, Y. https://orcid.org/0000-0001-9341-8104
• Bonneville, E.F. https://orcid.org/0000-0001-7542-4498
• Eikema, D.
• de Wreede, L.C. https://orcid.org/0000-0002-7667-9369
• Koster, L.
• Tuffnell, J.
• Passweg, J.
• Schetelig, J. https://orcid.org/0000-0002-2780-2981
• Platzbecker, U.
• Yakoub‐Agha, I.
• Salmenniemi, U.
• Verbeek, M.
• de Witte, M.A.
• Méar, J.
• Snowden, J.A. https://orcid.org/0000-0001-6819-3476
• Holderried, T.A.W.
• van Gorkom, G.
• Baron, F.
• Robin, M.
• Poiré, X.
• Roeven, M.W.H.
• Itälä‐Remes, M.
• Zaucha, J.
• Raj, K. https://orcid.org/0000-0002-8258-354X
• Drozd‐Sokolowska, J.
• Battipaglia, G.
• Czerw, T.
• Hernández‐Boluda, J.C. https://orcid.org/0000-0002-4289-3113
• Polverelli, N. https://orcid.org/0000-0001-6297-9697
• McLornan, D.P. https://orcid.org/0000-0003-1224-091X

© 2026 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in American Journal of Hematology is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

• Submitted: 10 October 2025
• Accepted: 13 March 2026
• Published (online): 20 March 2026
• Published: June 2026

• PubMed URL